Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Inventory (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Inventory data on record, last reported at $3.1 million in Q4 2025.

  • For Q4 2025, Inventory fell 23.99% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 23.99%, while the annual FY2025 figure was $3.1 million, 23.99% down from the prior year.
  • Inventory reached $3.1 million in Q4 2025 per TLSI's latest filing, down from $3.3 million in the prior quarter.
  • Across five years, Inventory topped out at $4.2 million in Q1 2025 and bottomed at $1.5 million in Q4 2022.
  • Average Inventory over 4 years is $3.1 million, with a median of $3.3 million recorded in 2025.
  • Peak YoY movement for Inventory: surged 145.49% in 2024, then decreased 23.99% in 2025.
  • A 4-year view of Inventory shows it stood at $1.5 million in 2022, then soared by 73.01% to $2.5 million in 2023, then surged by 59.06% to $4.0 million in 2024, then fell by 23.99% to $3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $3.1 million in Q4 2025, $3.3 million in Q3 2025, and $3.8 million in Q2 2025.